These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 24045262

  • 1. Factors affecting 18F-FDG uptake by metastatic lymph nodes in gastric cancer.
    Kim YH, Choi JY, Do IG, Kim S, Kim BT.
    J Comput Assist Tomogr; 2013; 37(5):815-9. PubMed ID: 24045262
    [Abstract] [Full Text] [Related]

  • 2. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
    Chung JH, Lee WW, Park SY, Choe G, Sung SW, Chung JK, Lee MC, Kim SE.
    Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnosis supporting algorithm for lymph node metastases from colorectal carcinoma on 18F-FDG PET/CT.
    Inoue K, Sato T, Kitamura H, Ito M, Tsunoda Y, Hirayama A, Kurosawa H, Tanaka T, Fukushi M, Moriyama N, Fujii H.
    Ann Nucl Med; 2008 Jan; 22(1):41-8. PubMed ID: 18250986
    [Abstract] [Full Text] [Related]

  • 10. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
    Yen TC, See LC, Lai CH, Yah-Huei CW, Ng KK, Ma SY, Lin WJ, Chen JT, Chen WJ, Lai CR, Hsueh S.
    J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M.
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [Abstract] [Full Text] [Related]

  • 13. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [Abstract] [Full Text] [Related]

  • 14. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles.
    Nakagawa T, Yamada M, Suzuki Y.
    J Nucl Med; 2008 Jul; 49(7):1053-9. PubMed ID: 18587087
    [Abstract] [Full Text] [Related]

  • 15. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 16. Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
    Krammer J, Wasser K, Schnitzer A, Henzler T, Schoenberg SO, Kaiser CG.
    Eur J Radiol; 2013 Dec; 82(12):2194-8. PubMed ID: 23993142
    [Abstract] [Full Text] [Related]

  • 17. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
    Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1506-12. PubMed ID: 15050330
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda T, Myoui A, Higuchi I, Yoshikawa H, Aozasa K, Hatazawa J.
    Ann Nucl Med; 2008 Oct 01; 22(8):699-705. PubMed ID: 18982473
    [Abstract] [Full Text] [Related]

  • 19. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
    Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E, Hölscher AH, Mönig SP.
    Nucl Med Commun; 2010 Jun 01; 31(6):532-8. PubMed ID: 20220543
    [Abstract] [Full Text] [Related]

  • 20. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
    Zhao Z, Yoshida Y, Kurokawa T, Kiyono Y, Mori T, Okazawa H.
    J Nucl Med; 2013 Apr 01; 54(4):499-506. PubMed ID: 23471314
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.